Capas, Baby Girl M.
HRN: 26-72-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/19/2025
03/01/2025
PO
6mL
Q8h
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes